Mod GRF 1-29 (CJC-1295 NO DAC) (5mg)

$46.00

Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) is offered by Biotech Peptides for laboratory and analytical research. Mod GRF 1-29 is a synthetic 29-residue GHRH analogue studied in relation to growth hormone-releasing hormone receptor signaling and somatotroph cell function. 1056

  • Product: Mod GRF 1-29

  • Alternative name: CJC-1295 without DAC

  • Listed quantity: 5 mg

  • Reference molecular formula: C₁₅₂H₂₅₂N₄₄O₄₂

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: Mod-GRF-1-29-5mg Category:
Description

Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) for Laboratory Research

Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) is offered by Biotech Peptides for laboratories investigating growth hormone-releasing hormone receptor signaling, somatotroph cell function, and growth hormone pulsatility dynamics. Mod GRF 1-29 is a synthetic 29-residue GHRH analogue with four stabilizing substitutions relative to native GHRH(1-29). 1056

For laboratories looking to buy Mod GRF 1-29, this listing identifies a 5 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Mod GRF 1-29 Product Information

Property Listing information
Product name Mod GRF 1-29
Alternative name CJC-1295 without DAC
Listed quantity 5 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 5 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.

Mod GRF 1-29 Reference Molecular Characteristics

The following characteristics describe the Mod GRF 1-29 reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length 29 residues
Reference sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Molecular formula C₁₅₂H₂₅₂N₄₄O₄₂
Approximate molecular weight 3367.9 g/mol
CAS number 863288-34-0
Chemical class Synthetic GHRH analogue

The sequence, molecular formula, molecular weight, and CAS number are documented in the Mod GRF 1-29 research summary and in the Mod GRF 1-29 research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1056

Mod GRF 1-29 and GHRH Receptor Research

Mod GRF 1-29 binds selectively to the GHRH receptor, a class B G-protein-coupled receptor expressed predominantly on somatotroph cells in the anterior pituitary. Receptor engagement activates adenylyl cyclase, increasing intracellular cyclic AMP concentrations. 1060

A review of GHRH receptor signaling describes GHRH-R as the most important GPCR in regulating GH release. The same review notes that GHRH-R is reportedly stimulated by LPS. 1054

Read the review of GHRH receptor signaling for the molecular mechanisms and evidence limitations.

Growth Hormone Pulsatility Research

A study evaluating a Modified GRF 1-29 analog reported that the peptide may enhance growth hormone release by 70% to 107% over a 12-hour period from somatotroph cells in the anterior pituitary gland. The same study reported an approximately 28% increase in IGF-1 levels. 1060

A separate study of CJC-1295, a long-acting GHRH analog, reported that the peptide promoted an increase in GH and IGF-1 levels in sera of healthy young adult men one week after administration.

These findings apply to specific experimental protocols and do not establish that a commercial Mod GRF 1-29 batch increases growth hormone in humans. 1060

Research Limitations

Published Mod GRF 1-29 research examines receptor signaling, cell-based assays, and animal models. It does not establish that Mod GRF 1-29 increases growth hormone, improves body composition, supports recovery, or treats any condition. 1054

Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.

Documentation and Batch Verification

Before selecting Mod GRF 1-29 (CJC-1295 NO DAC) (5mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.

For inquiries, provide “Mod GRF 1-29 (CJC-1295 NO DAC) (5mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About Mod GRF 1-29 (CJC-1295 NO DAC) (5mg)

What is Mod GRF 1-29?

Mod GRF 1-29 is a synthetic 29-residue GHRH analogue with four stabilizing substitutions relative to native GHRH(1-29). 1056

Is Mod GRF 1-29 the same as CJC-1295?

No. Mod GRF 1-29 is structurally identical to CJC-1295 without DAC. It is not the same molecule as CJC-1295 with DAC. 1057

Does Mod GRF 1-29 increase growth hormone?

A study evaluating a Modified GRF 1-29 analog reported that the peptide may enhance growth hormone release by 70% to 107% over a 12-hour period from somatotroph cells in the anterior pituitary gland. This does not establish that a commercial Mod GRF 1-29 batch increases growth hormone in humans. 1060

What does the 5mg designation mean?

It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery